BMP9-induced osteogenic differentiation is partially inhibited by miR-30a in the mesenchymal stem cell line C3H10T1/2

Journal of Molecular Histology

Volumn 46, Issue 4-5, 2015, Pages 399-407

  Zhang, Ruyi ^a   Weng, Yaguang ^a   Li, Baolin ^b   Jiang, Yingjiu ^a   Yan, Shujuan ^a   He, Fang ^a   Chen, Xiaoqing ^c   Deng, Fang ^a   Wang, Jing ^a   Shi, Qiong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 9; Mesenchymal stem cells; MiR 30a; Osteogenic differentiation; Runx2

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 9; CALCIUM; MICRORNA; MICRORNA 30A; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN30D MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; RNA INTERFERENCE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; OSTEOGENESIS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84939466229     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-015-9628-1     Document Type: Article

References (39)

1. Bai H, Weng Y, Bai S et al (2014) CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3 K-Akt pathway. Int J Oncol 45:333–343. doi:10.3892/ijo.2014.2421
2. Boraiah S, Paul O, Hawkes D, Wickham M, Lorich DG (2009) Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res 467:3257–3262. doi:10.1007/s11999-009-1039-8
3. Chen L, Jiang W, Huang J et al (2010) Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 25:2447–2459. doi:10.1002/jbmr.133
4. Chen L, Xiao H, Wang ZH, Huang Y, Liu ZP, Ren H, Song H (2014) miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. BMB Rep 47:39–44
5. Contador D, Ezquer F, Espinosa M, Arango-Rodriguez M, Puebla C, Sobrevia L, Conget P (2015) Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. Exp Biol Med. doi:10.1177/1535370214566565
6. de la Croix Ndong J, Stevens DM, Vignaux G et al (2015) Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx −/− mice. J Bone Miner Res 30:55–63. doi:10.1002/jbmr.2316
7. Ding W, Li J, Singh J et al (2015) miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE −/− mice. Cardiovasc Res 106:131–142. doi:10.1093/cvr/cvv030
8. Hyun J, Choi SS, Diehl AM, Jung Y (2014) Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKβ-deficient mouse. J Mol Histol 45:103–112
9. Jia J, Tian Q, Ling S, Liu Y, Yang S, Shao Z (2013) miR-145 suppresses osteogenic differentiation by targeting Sp7. FEBS Lett 587:3027–3031. doi:10.1016/j.febslet.2013.07.030
10. Koh JT, Zhao Z, Wang Z, Lewis IS, Krebsbach PH, Franceschi RT (2008) Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 87:845–849
11. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB (2000) Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11:1201–1210. doi:10.1089/10430340050015248
12. Kureel J, Dixit M, Tyagi AM et al (2014) miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell Death Dis 5:e1050. doi:10.1038/cddis.2014.4
13. Lamplot JD, Qin J, Nan G et al (2013) BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells 2:1–21
14. Li H, Li T, Wang S et al (2013) miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 10:313–324. doi:10.1016/j.scr.2012.11.007
15. Liu Q, He H, Zeng T, Huang Z, Fan T, Wu Q (2014) Neural-specific expression of miR-344-3p during mouse embryonic development. J Mol Histol 45:363–372
16. Liua XD, Caia F, Liu L, Zhang Y, Yang AL (2014) microRNA-210 is involved in the regulation of postmenopausal osteoporosis through promotion of VEGF expression and osteoblast differentiation. Biol Chem. doi:10.1515/hsz-2014-0268
17. Lv Z, Wang C, Yuan T et al (2014) Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/beta-catenin pathway. Oncol Rep 31:989–994. doi:10.3892/or.2013.2931
18. Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z, Zhao RC (2013) miR-21 modulates the ERK–MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem 114:1374–1384
19. Qadir AS, Um S, Lee H et al (2014) miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of mesenchymal stem cells. J Cell Biochem. doi:10.1002/jcb.25026
20. Roberto VP, Tiago DM, Silva IA, Cancela ML (2014) MiR-29a is an enhancer of mineral deposition in bone-derived systems. Arch Biochem Biophys 564:173–183. doi:10.1016/j.abb.2014.09.006
21. Rocca A, Marino A, Rocca V et al (2015) Barium titanate nanoparticles and hypergravity stimulation improve differentiation of mesenchymal stem cells into osteoblasts. Int J Nanomed 10:433–445. doi:10.2147/ijn.s76329
22. Rutherford RB, Nussenbaum B, Krebsbach PH (2003) Bone morphogenetic protein 7 ex vivo gene therapy. Drug News Perspect 16:5–10
23. Shui W, Zhang W, Yin L et al (2014) Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A 102:3429–3438. doi:10.1002/jbma.35006
24. Stern-Straeter J, Bonaterra GA, Juritz S et al (2014) Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells. Int J Mol Med 33:160–170. doi:10.3892/ijmm.2013.1555
25. van Wijnen AJ, van de Peppel J, van Leeuwen JP et al (2013) MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep 11:72–82. doi:10.1007/s11914-013-0143-6
26. Wang J, Zhang H, Zhang W et al (2014) Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev 23:1405–1416. doi:10.1089/scd.2013.0580
27. Wang Y, Yin Y, Jiang F, Chen N (2015) Human amnion mesenchymal stem cells promote proliferation and osteogenic differentiation in human bone marrow mesenchymal stem cells. J Mol Histol 46:13–20. doi:10.1007/s10735-014-9600-5
28. Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H (2012) miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 287:7503–7511. doi:10.1074/jbc.M111.292722
29. Wu B, Ma X, Zhu D et al (2013) Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro. J Mol Histol 44:423–431. doi:10.1007/s10735-013-9497-4
30. Yang M, Pan Y, Zhou Y (2014) miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells. FEBS Lett 588:4761–4768. doi:10.1016/j.febslet.2014.11.008
31. Ye G, Li C, Xiang X et al (2014) Bone morphogenetic protein-9 induces PDLSCs osteogenic differentiation through the ERK and p38 signal pathways. Int J Med Sci 11:1065–1072. doi:10.7150/ijms.8473
32. Zaragosi LE, Wdziekonski B, Brigand KL et al (2011) Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 12:R64. doi:10.1186/gb-2011-12-7-r64
33. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2011) A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA 108:9863–9868. doi:10.1073/pnas.1018493108
34. Zhang H, Wang J, Deng F et al (2015a) Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials 39:145–154. doi:10.1016/j.biomaterials.2014.11.007
35. Zhang Q, Tang Q, Qin D et al (2015b) Role of MicroRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 35:988–1000. doi:10.1128/mcb.01242-14
36. Zhao Y, Song T, Wang W et al (2012) P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS ONE 7:e43383. doi:10.1371/journal.pone.0043383
37. Zhao JJ, Lin J, Zhu D et al (2014) miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway. Cancer Res 74:1801–1813. doi:10.1158/0008-5472.can-13-3311-t
38. Zhong K, Chen K, Han L, Li B (2014) MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 14:703. doi:10.1186/1471-2407-14-703
39. Zhou C, Shen L, Mao L, Wang B, Li Y, Yu H (2015) miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem Biophys Res Commun 458:63–69. doi:10.1016/j.bbrc.2015.01.066